NCLEX Cardiac Medications Review

Cardiac medications show up all over the NCLEX-RN, and they intimidate many students because the drug list feels endless. The good news is that the exam rarely asks you to memorize an obscure fact in isolation. Instead it tests whether you understand a drug class — what it does, the key assessment before you give it, the teaching a client needs, and the sign that something has gone wrong. Master a handful of classes at that level and most cardiac pharmacology questions become predictable. This guide walks through the high-yield cardiovascular classes on the NCLEX: beta blockers, ACE inhibitors and ARBs, calcium channel blockers, diuretics, digoxin and antiarrhythmics, nitrates, and anticoagulants and antiplatelets. Drug names, doses, and monitoring parameters vary by source and facility, so always defer to your program’s pharmacology references, current drug guides, and the prescriber’s orders.

Beta blockers (“-olol”)

Beta blockers such as metoprolol, atenolol, and carvedilol slow the heart and lower blood pressure by blocking beta-adrenergic receptors. On the NCLEX, the recurring theme is rate and rhythm.

• Assess first: check the apical pulse for a full minute and the blood pressure before giving. A common teaching point is to hold the dose and notify the provider if the heart rate is below about 60 or the systolic pressure is low, per your facility’s parameters.
• Expected effects: lower heart rate, lower blood pressure, and reduced cardiac workload — used in hypertension, angina, dysrhythmias, and heart failure.
• Teach clients: never stop the drug abruptly, because sudden withdrawal can trigger rebound hypertension or chest pain. Rise slowly to avoid orthostatic hypotension.
• Watch for: bradycardia, fatigue, and masked signs of hypoglycemia in clients with diabetes. Nonselective agents may cause bronchoconstriction, so use caution in reactive airway disease.

When you see a beta blocker in a stem, your first move is almost always to check the pulse and blood pressure before administering.

ACE inhibitors and ARBs (“-pril” and “-sartan”)

ACE inhibitors (lisinopril, enalapril, captopril) and ARBs (losartan, valsartan) lower blood pressure and reduce cardiac and kidney strain by acting on the renin-angiotensin-aldosterone system. They are workhorses in hypertension and heart failure.

• Signature side effect of ACE inhibitors: a persistent dry cough. If it is bothersome, the provider may switch the client to an ARB, which is less likely to cause it.
• Serious risk: angioedema (swelling of the face, lips, or throat) is an emergency — stop the drug and get help. Both classes can raise potassium, so monitor for hyperkalemia and avoid salt substitutes that contain potassium.
• Monitor: blood pressure, renal function, and potassium. Watch for first-dose and orthostatic hypotension.
• Teach clients: these drugs are generally contraindicated in pregnancy; report any facial or throat swelling immediately.

Link the cues: a new dry cough points to an ACE inhibitor, and any swelling of the airway is a stop-the-drug emergency.

Calcium channel blockers (“-dipine”, diltiazem, verapamil)

Calcium channel blockers relax vascular smooth muscle and, depending on the agent, slow the heart. They treat hypertension, angina, and certain dysrhythmias.

• Dihydropyridines (amlodipine, nifedipine) mainly dilate vessels — expect lower blood pressure, peripheral edema, headache, and flushing.
• Non-dihydropyridines (diltiazem, verapamil) also slow heart rate, so check pulse and blood pressure before giving, much like a beta blocker.
• Teach clients: avoid grapefruit juice, which can raise drug levels; verapamil commonly causes constipation. Rise slowly to limit orthostatic hypotension.
• Watch for: hypotension and bradycardia, especially when these drugs are combined with a beta blocker.

Sort the class by ending: “-dipine” agents drop pressure and swell ankles, while diltiazem and verapamil behave more like rate-control drugs.

Diuretics: loop, thiazide, and potassium-sparing

Diuretics reduce fluid volume and blood pressure, and they are central to heart failure care. The NCLEX focuses heavily on their effect on potassium.

• Loop diuretics (furosemide) are potent and waste potassium — monitor for hypokalemia, and give slowly by IV to protect hearing (ototoxicity risk).
• Thiazides (hydrochlorothiazide) are milder and also lower potassium. For both, teach clients to eat potassium-rich foods unless told otherwise and to report muscle weakness or cramping.
• Potassium-sparing diuretics (spironolactone) retain potassium — here the risk is hyperkalemia, so avoid potassium supplements and salt substitutes.
• Monitor: daily weight, intake and output, blood pressure, and electrolytes. A gain of about 2–3 pounds in a day can signal fluid retention worth reporting.

The trap is potassium direction: most diuretics lower it, but the -sparing agents raise it. Match the potassium risk to the drug and the question usually solves itself.

Digoxin and antiarrhythmics

Digoxin strengthens contraction and slows the heart rate in heart failure and atrial fibrillation. It has a narrow therapeutic range, so it is a favorite NCLEX topic for safety.

• Before each dose: take the apical pulse for one full minute. A common rule is to hold and notify the provider if the adult rate is below about 60, per facility policy.
• Toxicity signs: nausea, vomiting, anorexia, visual changes (blurred or yellow-green vision), and new dysrhythmias. Report these promptly.
• Potassium matters: low potassium increases the risk of digoxin toxicity, which is one reason diuretic use is monitored so closely in these clients.
• Antiarrhythmics (such as amiodarone) have their own monitoring needs; follow the specific parameters, labs, and teaching your program and the drug reference provide.

For digoxin, remember the pattern: check the apical pulse, watch potassium, and treat GI and visual complaints as possible toxicity until proven otherwise.

Nitrates, anticoagulants, and antiplatelets

Two more high-yield groups round out cardiac pharmacology: drugs that relieve chest pain and drugs that manage clotting.

• Nitrates (nitroglycerin) dilate vessels to relieve angina. Teach clients to sit or lie down before use (it lowers blood pressure), expect a headache, store tablets in the original dark container, and follow the prescribed dosing schedule while seeking emergency care if chest pain is unrelieved.
• Anticoagulants: heparin is monitored with aPTT (antidote protamine sulfate); warfarin is monitored with PT/INR (antidote vitamin K). Teach warfarin clients to keep vitamin K intake consistent and to watch for bleeding.
• Antiplatelets (aspirin, clopidogrel) reduce clot formation; the main teaching is bleeding precautions — report bruising, dark stools, or bleeding that will not stop.
• Across all of these, the safety theme is bleeding risk; use a soft toothbrush, an electric razor, and caution with sharp objects.

Anchor each drug to its monitoring lab and antidote, and remember that anything affecting clotting brings bleeding precautions.

The bottom line

Cardiac pharmacology on the NCLEX rewards class-level thinking rather than rote memorization. Check the apical pulse and blood pressure before beta blockers, rate-slowing calcium channel blockers, and digoxin; connect an ACE inhibitor to a dry cough and any airway swelling to emergency angioedema; and always track the potassium direction of a diuretic. Tie digoxin toxicity to low potassium and GI or visual complaints, teach nitrate clients to sit down and seek help for unrelieved chest pain, and pair every anticoagulant and antiplatelet with bleeding precautions and its monitoring lab. Because drug names, values, and protocols differ by source, always follow your program’s references and the prescriber’s orders. Then use the free NCLEX-RN practice questions below to see these medication classes tested in realistic clinical scenarios.